Call Options

16 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2022

Feb 08, 2023

SELL
$76.18 - $87.74 $2.32 Million - $2.67 Million
-30,400 Reduced 67.71%
14,500 $1.13 Million
Q3 2022

Oct 25, 2022

SELL
$80.75 - $95.31 $48,450 - $57,186
-600 Reduced 1.32%
44,900 $19,000
Q2 2022

Aug 12, 2022

SELL
$87.4 - $113.09 $305,900 - $395,815
-3,500 Reduced 7.14%
45,500 $26,000
Q1 2022

May 11, 2022

SELL
$100.58 - $112.38 $181,044 - $202,284
-1,800 Reduced 3.54%
49,000 $32,000
Q4 2021

Feb 08, 2022

SELL
$99.53 - $127.75 $308,543 - $396,025
-3,100 Reduced 5.75%
50,800 $19,000
Q3 2021

Nov 02, 2021

BUY
$122.75 - $135.17 $1.36 Million - $1.5 Million
11,100 Added 25.93%
53,900 $32,000
Q2 2021

Aug 11, 2021

SELL
$118.19 - $131.5 $2 Million - $2.22 Million
-16,900 Reduced 28.31%
42,800 $40,000
Q1 2021

May 14, 2021

BUY
$111.18 - $119.74 $678,198 - $730,414
6,100 Added 11.38%
59,700 $36,000
Q4 2020

Feb 12, 2021

SELL
$100.57 - $117.14 $2.06 Million - $2.4 Million
-20,500 Reduced 27.67%
53,600 $57,000
Q3 2020

Nov 04, 2020

BUY
$90.13 - $108.78 $2.43 Million - $2.94 Million
27,000 Added 57.32%
74,100 $117,000
Q2 2020

Jul 28, 2020

SELL
$84.11 - $103.33 $1.18 Million - $1.45 Million
-14,000 Reduced 22.91%
47,100 $6,000
Q1 2020

Apr 21, 2020

SELL
$72.92 - $121.3 $3.06 Million - $5.09 Million
-42,000 Reduced 40.74%
61,100 $19,000
Q4 2019

Feb 12, 2020

BUY
$104.49 - $114.54 $2.1 Million - $2.3 Million
20,100 Added 24.22%
103,100 $160,000
Q3 2019

Nov 07, 2019

SELL
$98.02 - $111.18 $1.99 Million - $2.26 Million
-20,300 Reduced 19.65%
83,000 $246,000
Q2 2019

Aug 06, 2019

BUY
$84.15 - $99.38 $5.74 Million - $6.78 Million
68,200 Added 194.3%
103,300 $63,000
Q2 2017

Aug 14, 2017

BUY
N/A
35,100
35,100 $235,000

Others Institutions Holding MDT

About Medtronic plc


  • Ticker MDT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,329,149,952
  • Market Cap $114B
  • Description
  • Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...
More about MDT
Track This Portfolio

Track Raymond James & Associates Portfolio

Follow Raymond James & Associates and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.